The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global clot management devices market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 5.1% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Clot management devices refer to the medical equipment that are used for the treatment of ailments such as pulmonary embolism (PE), arterial blood clots and deep vein thrombosis (DVT). Some of the commonly used clot management devices include catheter-directed thrombolysis (CDT) devices, embolectomy balloon catheters, percutaneous thrombectomy devices, neurovascular embolectomy devices and inferior vena cava filters (IVCFs). These devices aid in inhibiting the development of blood clots in the heart, brain, lungs and legs of the patient, thereby preventing the instances of potential ischemic strokes, severe leg pain and heart attacks.
The increasing prevalence of cardiovascular diseases (CVDs), along with the rising geriatric population across the globe, is one of the key factors driving the growth of the market. Owing to the sedentary lifestyles and unhealthy dietary habits, a greater number of individuals are suffering from heart ailments, DVT and PE, thereby enhancing the demand for clot management devices. Furthermore, the growing preference for minimally invasive (MI) procedures by both patients and healthcare providers is also boosting the market growth. For instance, mechanical thrombectomy is an MI procedure in which the surgeon uses specialized equipment to remove the clot from the patient’s artery through a small incision. Apart from this, the increasing instances of hip, knee and spinal injuries that require catheter-directed thrombolysis, have also created a positive impact on the market growth. Other factors, including various technological advancements, such as the development of next-generation thrombectomy devices, the continual launch of cost-effective devices, along with extensive research and development (R&D) activities in the field of medical sciences, are projected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global clot management devices market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on product type and end-use.
Breakup by Product Type:
Breakup by End-User:
Breakup by Region:
The report has also analysed the competitive landscape of the market with some of the key players being AngioDynamics Inc., Argon Medical Devices Inc., Boston Scientific Corporation, DePuy Synthes Inc., Edwards Lifesciences Corporation, iVascular S.L.U., Lemaitre Vascular Inc., Medtronic Inc., Straub Medical AG, Stryker Corporation, Teleflex Incorporated, Vascular Solutions, etc.
|Base Year of the Analysis||2020|
|Segment Coverage||Product Type, End-User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||AngioDynamics Inc., Argon Medical Devices Inc., Boston Scientific Corporation, DePuy Synthes Inc., Edwards Lifesciences Corporation, iVascular S.L.U., Lemaitre Vascular Inc., Medtronic Inc., Straub Medical AG, Stryker Corporation, Teleflex Incorporated and Vascular Solutions|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at